The Claim
In genetically heterogeneous UM-HET3 mice, administration of dimethyl fumarate at an average dose of 42 ppm (35% of the target 120 ppm) was not associated with a change in lifespan.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
In a specific strain of mice, a low dose of dimethyl fumarate did not extend lifespan compared to expected outcomes at the full dose.
See the scientific wording
In genetically heterogeneous UM-HET3 mice, dimethyl fumarate was administered at an average of only 35% of the target dose (42 ppm vs. 120 ppm), and no lifespan effect was observed, suggesting that insufficient exposure may have masked a potential benefit.
Dimethyl fumarate turns on a cellular defense system that cleans up harmful molecules and protects cells from damage, which can slow aging and extend life — but only if enough of the compound reaches the cells.
What the research says
1 studyThe scientists gave mice less of the medicine than they planned, and the mice didn’t live longer — but the study says this might be because they didn’t give enough, not because the medicine doesn’t work.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.